Actionable news
All posts from Actionable news
Actionable news in CHMA: CHIASMA Inc COMMON STOCK,

Impending PDUFA Dates Offer Opportunity for Large Move in Pharmaceutical Companies

NEW YORK, NY / ACCESSWIRE / April 12, 2016 / Chiasma, Inc. (CHMA), KemPharm, Inc. (KMPH), Lipocine Inc. (LPCN), and Vanda Pharmaceuticals Inc. (VNDA) have PDUFA dates scheduled over the next couple of months which could significantly alter the prospects for the companies.

What could a positive response from the FDA mean for the company's stock price?

Get an analyst report highlighting the investment prospects for CHMA, KMPH, LPCN, and VNDA please follow this link. There is no cost obligation required to view analyst brief:


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the subject...